For patients waiting for funded access to a medicine, the PBS decision-making framework must sometimes appear like Banquo’s ghost, an ever-present shadow reminding them of a grim reality.
An outcome that might haunt the system's decision-making, like Banquo's ghost
August 25, 2025 Latest NewsBioPharmaComment
Latest Video
New Stories
-
Botanix appoints Dr Patricia Walker as a non-executive director
August 25, 2025 - - Australian Biotech -
First site initiated for Neuren’s Phelan-McDermid syndrome Phase 3 trial
August 25, 2025 - - Australian Biotech -
Argent BioPharma announces results of independent in vivo study
August 25, 2025 - - Australian Biotech -
An outcome that might haunt the system's decision-making, like Banquo's ghost
August 25, 2025 - - Latest News -
PBAC delivers recommendations dominated by price cuts and risk shares
August 25, 2025 - - Latest News -
Disappointment as committee stalls again on broad listing for cancer immunotherapies
August 25, 2025 - - Latest News -
World-first clinical trial reveals unprecedented insights into brain cancer treatment
August 24, 2025 - - Australian Biotech